A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Condition(s):Relapsed Advanced LymphomasLast Updated:January 31, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Relapsed Advanced LymphomasLast Updated:January 31, 2024Recruiting
Condition(s):Relapsed Malignant Solid NeoplasmLast Updated:January 31, 2024Recruiting
Condition(s):Relapse; Advanced Malignant Neoplasm; Non Small Cell Lung Cancer; Gastric Cancer; Urothelial Carcinoma; Kidney Cancer; Colon Cancer; Esophagus CancerLast Updated:January 31, 2024Recruiting
Condition(s):Solid Tumor, Adult; Acute Myeloid Leukemia; Myelodysplastic Syndromes; Non Hodgkin LymphomaLast Updated:January 31, 2024Recruiting
Condition(s):Solid Tumor, Adult; Non-hodgkin Lymphoma; Hodgkin LymphomaLast Updated:January 31, 2024Recruiting
Condition(s):Plaque PsoriasisLast Updated:December 13, 2022Completed
Condition(s):Chronic Plaque-type PsoriasisLast Updated:August 14, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.